Table 2.
Proportion of patients with worsening assessment scores at week 12
| Abiraterone n = 28 n (%) |
Enzalutamide n = 28 n (%) |
P value | |
|---|---|---|---|
| BOMC | 8 (29) | 11 (39) | 0.57 |
| GDS | 8 (29) | 13 (46) | 0.27 |
| FRQ | 14 (50) | 15 (54) | >0.99 |
BOMC, Blessed Orientation-Memory-Concentration; GDS, Geriatric Depression Scale; FRQ, Falls Risk Questionnaire.